Vertex Pharmaceuticals
VRTX
$473.69
Share price
-1.46%
Change (1 day)
36.16%
Change (1 year)
Categories
Vertex Pharmaceuticals (VRTX) - Net assets
Net assets on the balance sheet as of March 2024 : $18.54 B
According to Vertex Pharmaceuticals's latest financial reports the company has $18.54 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Vertex Pharmaceuticals - Net assets on balance sheet (from 2001 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $17.58 B | 26.36% |
| 2022-12-31 | $13.91 B | 37.75% |
| 2021-12-31 | $10.10 B | 16.27% |
| 2020-12-31 | $8.68 B | 42.75% |
| 2019-12-31 | $6.08 B | 37.2% |
| 2018-12-31 | $4.43 B | 117.17% |
| 2017-12-31 | $2.04 B | 52.62% |
| 2016-12-31 | $1.33 B | 22.36% |
| 2015-12-31 | $1.09 B | -0.23% |
| 2014-12-31 | $1.09 B | -19.18% |
| 2013-12-31 | $1.35 B | 13.43% |
| 2012-12-31 | $1.19 B | 28.8% |
| 2011-12-31 | $0.92 B | 84.23% |
| 2010-12-31 | $0.50 B | -54.03% |
| 2009-12-31 | $1.09 B | 358.96% |
| 2008-12-31 | $0.23 B | -11.95% |
| 2007-12-31 | $0.27 B | -46.38% |
| 2006-12-31 | $0.50 B | 111.53% |
| 2005-12-31 | $0.23 B | 574.86% |
| 2004-12-31 | $35.44 M | -81.62% |
| 2003-12-31 | $0.19 B | -49.06% |
| 2002-12-31 | $0.37 B | -20.36% |
| 2001-12-31 | $0.47 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $70.02 B | 277.54% | 🇺🇸 USA |
 AbbVie ABBV | $8.04 B | -56.61% | 🇺🇸 USA |
 Gilead Sciences GILD | $17.45 B | -5.89% | 🇺🇸 USA |
 Merck MRK | $40.42 B | 117.96% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $16.54 B | -10.78% | 🇺🇸 USA |
 Enanta Pharmaceuticals
ENTA | $0.16 B | -99.10% | 🇺🇸 USA |